Aldosterone and Angiogenesis
Open Access
- 1 September 2010
- journal article
- editorial
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 23 (9) , 940
Abstract
Since its discovery in the early 1950s, aldosterone has been shown to have a major influence on renal electrolyte transport. However, it is now known that aldosterone also has important actions to promote fibrosis,1 thrombosis,2 and vascular inflammation.3 An action which has received much less consideration is the ability of aldosterone to influence angiogenesis. Angiogenesis is the formation of new blood vessels. The regulation of angiogenesis is through the release of stimulatory growth factors such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and angiopoietins or inhibitory factors such as angiostatin and endostatin. Studies by Suzuki and coworkers showed that treatment with the selective mineralocorticoid receptor (MR) antagonist eplerenone (20 mg/kg/day) for 3 months in dogs subjected to progressive left ventricular dysfunction as a consequence of intracoronary microembolization substantially increased myocardial capillary density and basic FGF.4 These changes were accompanied by an improvement in cardiac ejection fraction and no change in arterial blood pressure. An increase in cardiac angiogenesis would be of particular benefit in patients postmyocardial infarction as it can provide blood flow and oxygen to support metabolism.Keywords
This publication has 9 references indexed in Scilit:
- Effect of Eplerenone on Endothelial Progenitor Cells and Oxidative Stress in Ischemic HindlimbAmerican Journal of Hypertension, 2010
- Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-AnalysisAmerican Journal of Hypertension, 2010
- Effects of Long-Term Monotherapy With Eplerenone, a Novel Aldosterone Blocker, on Progression of Left Ventricular Dysfunction and Remodeling in Dogs With Heart FailureCirculation, 2002
- Aldosterone induces a vascular inflammatory phenotype in the rat heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Aldosterone as a Mediator in Cardiovascular InjuryCardiology in Review, 2002
- Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivoKidney International, 2000
- Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.Circulation, 1991
- Angiotensin formation in the isolated rat hindlimbJournal Of Hypertension, 1989
- Development of microvascular rarefaction in the spontaneously hypertensive ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 1982